Short communication · 28 Jan 2022
Conference abstractPublished 5 Sep 2016
Formulation selection matrix in early clinical formulation
Director, BioDuro- LLC, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The pharmaceutical formulation development of early stage pre-clinical and clinical formulations poses various unique challenges during development. These challenges are mainly related to limited physicochemical data, limited availability of drug substances, uncertainty on dosage ranges, solubilization/ in-vivo exposure challenges, further scalability considerations for clinical manufacturing etc. The presentation covers an opportunity area for formulation selection matrix based on Data Driven Decision (DDD) making during developability assessment and solution engine that can facilitates overall development approach. Over 60% of New Chemical Entities (NCE’s) under development are poorly soluble therefore, it is always challenging to select appropriate development platform. The presentation covers and describes technology selection such as microevaporation, amorphous solid dispersions using spray drying or hot melt extrusion (HME) and few case studies describing the same. Overall, appropriate assessment of early stage data can help to successfully develop formulations within defined timeframe with limited usage of drug substances. These formulations can be further evaluated in animal models or first in human (FIH) clinical studies to understand in-vivo performance followed by phase appropriate scale up.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Aug 2018
Translating research to practice: The role of evaluation for policy formulation, clinical applicability and intelligent – led prevention strategies and early detection and treatment specificity
Article · 10 Jan 2025
Extraction of FSM and Formulation of Metformin Sustained Release Matrix Tablets
Perspective · 23 Dec 2024
Polymeric Matrix Formulations for Drug Release of Valsartan
Commentary · 14 Apr 2022
Improvement of Controlled Release Matrix Formulations of the Chronobiotic Hormone
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Anand Kulkarni”
